NCT06678581View on ClinicalTrials.gov

SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 29, 2023

Primary Completion Date

December 20, 2023

Study Completion Date

January 11, 2024

Conditions
GoutHyperuricemia
Interventions
DRUG

SAP-001

Solid Oral Tablet

DRUG

Placebo

Solid Oral Tablet

Trial Locations (1)

Unknown

Huashan Hospital Affiliated to Fudan University, Shanghai

All Listed Sponsors
lead

Shanton Pharma Co., Ltd.

INDUSTRY

NCT06678581 - SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects | Biotech Hunter | Biotech Hunter